Dana-Farber Cancer Institute /ID# 214832

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer, Cancer

Studies at this site

• A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy — Stopped early